Ozempic and Wegovy Gastroparesis Claims

People taking Ozempic or Wegovy who develop persistent nausea, vomiting, early fullness, or difficulty eating may need medical evaluation for delayed stomach emptying. Gastroparesis is a condition in which the stomach empties more slowly than normal. Symptoms can have many causes, and an individual diagnosis does not by itself establish that a medication caused the condition.

What the semaglutide labels say

Current U.S. prescribing information for Ozempic and Wegovy states that semaglutide delays gastric emptying. The labels also say these medicines are not recommended for people with severe gastroparesis. That information is relevant to a medical review, but it does not determine what caused a particular person’s symptoms or establish that every user faces the same risk. A treating clinician should guide diagnosis and any medication decisions. See the current FDA-approved Ozempic prescribing information and Wegovy prescribing information.

Symptoms that deserve medical attention

Possible gastroparesis symptoms can include nausea, vomiting, feeling full soon after starting a meal, prolonged fullness after eating, abdominal discomfort, and reduced appetite. Symptoms overlap with other conditions and medication effects. Seek prompt medical care for severe or worsening symptoms, inability to keep fluids down, signs of dehydration, or other urgent concerns. Do not stop or change a prescribed medicine without discussing it with your prescriber.

How doctors evaluate delayed stomach emptying

A clinician may review the timing of symptoms, medication history, diabetes and other health conditions, and alternative explanations. Testing may be used when appropriate to assess stomach emptying. The evaluation belongs to the patient’s healthcare team; this page is general information and is not medical advice.

When a legal review may be appropriate

A legal review can look at the full timeline: when semaglutide was started or adjusted, when symptoms began, what the medical records show, what testing found, whether other conditions could explain the symptoms, and what treatment or losses followed. A potential claim depends on evidence and applicable law. The fact that a drug can delay gastric emptying does not alone prove that it caused gastroparesis in a particular patient, that a warning was legally inadequate, or that compensation is available. No outcome can be promised.

Keep medication and pharmacy records, visit notes, test results, and a dated account of symptoms and treatment. Preserve records in their original form and follow your clinician’s advice. A lawyer can assess whether more information is needed and whether any filing deadline may apply; deadlines vary by state and circumstances.

Related semaglutide injury information

• Ozempic and Wegovy injury claims overview
• Ileus and bowel obstruction claims
• Aspiration during anesthesia claims

Talk with Logue Law Group

If you or a family member was diagnosed with gastroparesis after using Ozempic or Wegovy, Logue Law Group can review the available information and discuss whether a further legal evaluation may be useful. Contacting the firm does not create an attorney-client relationship, and an individual review is needed to assess any matter.